General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Deli… (NCT04477928) | Clinical Trial Compass
RecruitingNot Applicable
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
United States33,000 participantsStarted 2020-07-17
Plain-language summary
In partnership with Helmsley Charitable Trust, the Sanford PLEDGE Study is a large-scale, observational, feasibility study of general population screening for T1D and celiac autoantibodies. Screening is incorporated into routine health care visits within an integrated health system.
Who can participate
Age range0 Minutes – 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Newborn Entry: Viable, term infants, defined as 36 weeks gestation by either dates or ultrasound who are born to pregnant women, 18 years or older, who are willing and able to provide informed consent (IC) prior to the onset of active labor. Who are born at a Sanford Health Hospital and plan to have routine well-child care at a Sanford Clinic
* Pediatric Entry: Children less than 6 years of age who receive their routine care at a Sanford facility and whose parents are able to provide IC.
* Adolescent Entry: Children, ages 9-16 years old, who receive their routine care at a Sanford facility and whose parents are able to provide IC.
* Siblings of children known to have T1D-relevant antibodies; ages 6 to 17 years old who receive care at a Sanford clinic
* Have an active MyChart account (with proxy access).
Exclusion Criteria:
* Subject is in the opinion of the investigator, unable to comply with the requirements of the study protocol.
* Children known to have T1D
What they're measuring
1
Demonstrated feasibility of large-scale population screening, as evidenced by: